{"disease":{"id":"diarrhea-infectious","name":"diarrhea infectious"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05766826","title":"Coupons for Safe Water Project","phase":"NA","overall_status":"RECRUITING","enrollment_count":3468,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT05166850","title":"Preventative Intervention for Cholera for 7 Days","phase":"NA","overall_status":"RECRUITING","enrollment_count":2900,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT06498817","title":"Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)","phase":"NA","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT04312906","title":"A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in Africa","phase":"","overall_status":"COMPLETED","enrollment_count":1334,"lead_sponsor_name":"Centre for Infectious Disease Research in Zambia","has_results":false},{"nct_id":"NCT07195006","title":"Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories","phase":"","overall_status":"RECRUITING","enrollment_count":368,"lead_sponsor_name":"University of Zimbabwe","has_results":false},{"nct_id":"NCT04423159","title":"Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)","phase":"NA","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Centre for Infectious Disease Research in Zambia","has_results":false},{"nct_id":"NCT04237181","title":"Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ER","phase":"NA","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05409196","title":"Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Eveliqure Biotechnologies GmbH","has_results":false},{"nct_id":"NCT05770726","title":"Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT05933525","title":"Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Immuron Ltd.","has_results":false},{"nct_id":"NCT06896136","title":"Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Mark Klempner","has_results":false},{"nct_id":"NCT04602676","title":"The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT07257705","title":"Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of Milano Bicocca","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}